Form D · Other Investment Fund

22C Target Pharma Investors Rollover, LLC

New York, NY · CIK 0001746768

Offering snapshot reported Jul 23, 2018 · SEC filing

Reported sold: $18.3M
Investors reported: 4
Minimum accepted: $0
First sale: Jun 28, 2018

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jul 23, 2018	Initial	$18,250,000	No comparison	4	SEC filing

Offering details

Securities: Equity, Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: Yes

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-317493

Source: Form D, filed Jul 23, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

22C TARGET PHARMA INVESTORS ROLLOVER, LLC

Investment adviser: 22C CAPITAL LLC

Gross asset value: $18.3M
Beneficial owners: 5
ADV minimum commitment: $0

Reported in Form ADV on Jun 27, 2019. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator EAS ACCOUNTING SERVICES, CPA LLC NEW YORK, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Custodian M.Y. SAFRA BANK, FSB NEW YORK, New York, United States Related to adviser: No

Provider details

Annual audit: No
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

M.Y. SAFRA BANK, FSB
LEI 549300I68TD716GMAB09

Filing source

Form ADV 1331899 · Jun 27, 2019 · Schedule D 7.B.(1), fund 805-6504773233

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Eric Edell	Executive
D. Randall Winn	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

70 E 55 Th Street, 14 Th Floor
New York, NY, 10022